Pneumonia Pathogens: Bacteria, Viruses & Fungi

What Are Pneumonia Pathogens?

Pneumonia pathogens are microorganisms capable of causing pneumonia -- an infection and inflammation of the lung tissue, particularly affecting the alveoli (air sacs) and surrounding structures. The condition can be triggered by bacteria, viruses, fungi, or parasites. Identifying the causative pathogen is essential for selecting the appropriate treatment.

Bacterial Pathogens

Bacteria are the most common cause of pneumonia in adults. The most clinically relevant bacterial pathogens include:

• Streptococcus pneumoniae (Pneumococcus): The leading cause of community-acquired pneumonia (CAP), often presenting with sudden high fever, chills, and productive cough.
• Haemophilus influenzae: Particularly significant in patients with chronic obstructive pulmonary disease (COPD) or other underlying lung conditions.
• Mycoplasma pneumoniae: A classic cause of atypical pneumonia, especially in young adults and school-age children, with a gradual onset.
• Chlamydophila pneumoniae: Another atypical pneumonia pathogen with mild, slowly progressive symptoms.
• Legionella pneumophila: Causes Legionnaires disease, typically spread through contaminated water systems such as cooling towers or air conditioning units.
• Staphylococcus aureus: Can cause severe, necrotizing pneumonia, often as a secondary infection following influenza.
• Klebsiella pneumoniae: A common cause of hospital-acquired pneumonia, particularly in immunocompromised or critically ill patients.
• Pseudomonas aeruginosa: Frequently implicated in ventilator-associated pneumonia and in patients with cystic fibrosis.

Viral Pathogens

Viruses are the predominant cause of pneumonia in children and are also common in elderly individuals. Key viral pathogens include:

• Influenza viruses (Type A and B): Can cause primary viral pneumonia or predispose patients to secondary bacterial superinfections.
• SARS-CoV-2: The causative agent of COVID-19, known for triggering severe interstitial pneumonia in some patients.
• Respiratory Syncytial Virus (RSV): The most frequent cause of viral pneumonia in infants and young children.
• Parainfluenza viruses: Predominantly affect children and can lead to croup as well as pneumonia.
• Adenoviruses: Can produce severe pneumonia, particularly in immunocompromised individuals.
• Cytomegalovirus (CMV): A serious opportunistic pathogen in immunosuppressed patients, such as transplant recipients.

Fungal Pathogens

Fungal pneumonias primarily affect individuals with weakened immune systems and can be life-threatening:

• Aspergillus fumigatus: Responsible for invasive aspergillosis in neutropenic patients.
• Pneumocystis jirovecii: Causes Pneumocystis pneumonia (PCP), classically seen in HIV-positive patients with low CD4 cell counts.
• Candida spp.: An uncommon cause of pneumonia, usually arising in the context of systemic candidiasis.
• Histoplasma capsulatum and Cryptococcus neoformans: Relevant in specific geographic regions or in patients with immune deficiencies.

Classification by Site of Acquisition

Pneumonias are clinically classified by where they are acquired, as this provides important clues about the likely pathogens involved:

• Community-acquired pneumonia (CAP): Develops outside the hospital setting. Most common pathogens: Streptococcus pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae.
• Hospital-acquired pneumonia (HAP): Occurs at least 48 hours after hospital admission. Common pathogens: Klebsiella pneumoniae, Pseudomonas aeruginosa, MRSA.
• Ventilator-associated pneumonia (VAP): Develops in patients on mechanical ventilation. Often involves multidrug-resistant organisms.

Symptoms of Pneumonia

Regardless of the causative pathogen, pneumonia commonly presents with the following symptoms:

• High fever, often accompanied by chills and rigors
• Cough, frequently productive with yellow-green or rust-colored sputum
• Shortness of breath and rapid breathing (tachypnea)
• Chest pain that worsens with breathing or coughing (pleuritic pain)
• General malaise, fatigue, and loss of appetite
• In atypical pneumonia: gradual onset with dry cough, headache, and low-grade fever

Diagnosis

Identifying the causative pathogen and confirming the diagnosis of pneumonia involves several approaches:

• Physical examination: Auscultation of the lungs may reveal crackles or decreased breath sounds.
• Chest X-ray: Demonstrates pulmonary infiltrates (opacities) characteristic of consolidation.
• CT scan of the chest: Used for complex or unclear cases.
• Laboratory tests: Full blood count, C-reactive protein (CRP), procalcitonin as inflammatory markers; arterial blood gases in cases of respiratory distress.
• Microbiological testing: Blood cultures, sputum culture, urinary antigen tests (for pneumococcus and Legionella), PCR assays for viruses (influenza, SARS-CoV-2, Mycoplasma).
• Bronchoscopy with BAL: Bronchoalveolar lavage for direct sampling in immunocompromised patients or diagnostically challenging cases.

Treatment

Treatment is guided by the identified pathogen, disease severity, and the immune status of the patient:

• Bacterial pneumonia: Antibiotic therapy, e.g., amoxicillin, macrolides (azithromycin, clarithromycin), or fluoroquinolones. Severe cases require hospitalization and intravenous antibiotics.
• Viral pneumonia: Antiviral therapy with oseltamivir for influenza; for COVID-19, antivirals (nirmatrelvir/ritonavir) or corticosteroids (dexamethasone) depending on severity.
• Fungal pneumonia: Antifungal agents such as voriconazole (aspergillosis) or trimethoprim-sulfamethoxazole (PCP).
• Supportive care: Supplemental oxygen, intravenous fluids, antipyretics, and mechanical ventilation if required.

Prevention

Several effective preventive measures are available to reduce the risk of pneumonia:

• Vaccination: Pneumococcal vaccine (recommended for children, adults aged 60 and over, and high-risk groups), annual influenza vaccine, COVID-19 vaccine, and RSV vaccine for vulnerable populations.
• Hygiene measures: Regular handwashing, respiratory etiquette (covering the mouth and nose when coughing or sneezing).
• Reducing risk factors: Smoking cessation, management of underlying conditions such as diabetes or COPD.

References

1. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2007;44(Suppl 2):S27-S72.
2. World Health Organization (WHO): Pneumonia -- Key Facts. Geneva, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/pneumonia
3. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71-79. DOI: 10.1136/thx.2009.129502